D'cruz Rakhi, Anjana T, Shaji Mathew
Chaithanya eye hospital and research centre, Kollam, Kerala, India.
Ahalia eye hospital, Kollam, Kerala, India.
Int J Surg Case Rep. 2025 Sep;134:111650. doi: 10.1016/j.ijscr.2025.111650. Epub 2025 Jul 10.
Inflammatory type 1 CNVM is a severe but uncommon complication associated with posterior uveitis.
We report a case of type 1 CNVM in a 50-year-old man with a documented history of viral ocular infection. Although inflammatory CNVM is frequently associated with posterior uveitis due to tuberculosis and toxoplasmosis, its occurrence secondary to viral uveitis is rare. The patient's medical history included fever followed by viral conjunctivitis accompanied by superficial punctate keratopathy, for which he was undergoing treatment elsewhere. Despite treatment, he continued to experience pain, redness, photophobia, and metamorphopsia. Upon presentation at our centre,one month following the initial symptoms, a diagnosis of posterior uveitis and CNVM was established, which had not been detected during prior ophthalmological examinations. The subsequent administration of intravitreal anti-VEGF agents along with oral corticosteroids resulted in a dramatic resolution of CNVM.
To the best of our knowledge, similar case that started with viral conjunctivitis, anterior uveitis and later progressed to posterior uveitis with a type 1 CNVM has not been reported till date. Inflammatory cells released during uveitis can lead to breakage of Bruch's-RPE complex and lead to CNVM. There is no proper consensus in treating inflammatory CNVM.A combination of intravitreal anti-VEGF agents and intravitreal steroids or oral steroids have been tried by various studies.
Unilateral CNVM developed within one month following an episode of posterior uveitis that initially presented as viral conjunctivitis. Early recognition and timely management with intravitreal anti-VEGF therapy combined with systemic corticosteroids resulted in a favorable visual outcome, with no recurrences observed during the follow-up period.
炎症性1型脉络膜新生血管(CNVM)是一种与后葡萄膜炎相关的严重但不常见的并发症。
我们报告一例50岁男性的1型CNVM病例,该患者有病毒性眼部感染病史。尽管炎症性CNVM常与结核和弓形虫病引起的后葡萄膜炎相关,但其继发于病毒性葡萄膜炎的情况罕见。患者的病史包括发热后出现病毒性结膜炎并伴有浅层点状角膜炎,他正在其他地方接受治疗。尽管进行了治疗,他仍持续出现疼痛、眼红、畏光和视物变形。在最初症状出现一个月后到我们中心就诊时,确诊为后葡萄膜炎和CNVM,之前的眼科检查未检测到。随后玻璃体腔内注射抗血管内皮生长因子(VEGF)药物并联合口服皮质类固醇,使CNVM显著消退。
据我们所知,迄今为止尚未报道过类似先出现病毒性结膜炎、前葡萄膜炎,随后进展为伴有1型CNVM的后葡萄膜炎的病例。葡萄膜炎期间释放的炎症细胞可导致布鲁赫膜-视网膜色素上皮(RPE)复合体破裂并导致CNVM。在治疗炎症性CNVM方面尚无适当的共识。各种研究尝试了玻璃体腔内抗VEGF药物与玻璃体腔内类固醇或口服类固醇的联合应用。
单侧CNVM在最初表现为病毒性结膜炎的后葡萄膜炎发作后一个月内发生。早期识别并及时采用玻璃体腔内抗VEGF治疗联合全身皮质类固醇治疗,取得了良好的视觉效果,随访期间未观察到复发。